Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,294 papers from all fields of science
Search
Sign In
Create Free Account
Non-Measurable Tumor Identification
Known as:
NON-MEASURABLE
The identification of a tumor that is incapable of being measured at baseline.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Clinical Data Interchange Standards Consortium Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube.
T. Herzog
,
B. Monk
,
+9 authors
B. Childs
Gynecologic Oncology
2014
Corpus ID: 21555858
2013
2013
On relativistic entanglement and localization of particles and on their comparison with the nonrelativistic theory
H. Crater
,
L. Lusanna
2013
Corpus ID: 119211368
We make a critical comparison of relativistic and nonrelativistic classical and quantum mechanics of particles in inertial frames…
Expand
Review
2013
Review
2013
Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer
H. Lee
,
H. Kim
,
N. Park
,
H. Chung
,
J. W. Kim
,
Y. Song
Cancer research and treatment : official journal…
2013
Corpus ID: 23773306
Purpose The purpose of this study is to evaluate the efficacy and toxicity of oxaliplatin, leucovorin, and 5-fluorouracil (FOLFOX…
Expand
2009
2009
Safety and efficacy of AMG 655 plus modified FOLFOX6 (mFOLFOX6) and bevacizumab (B) for the first-line treatment of patients (pts) with metastatic colorectal cancer (mCRC).
L. Saltz
,
J. Infante
,
+7 authors
C. Fuchs
Journal of Clinical Oncology
2009
Corpus ID: 42399838
4079 Background: AMG 655 is an investigational fully human monoclonal antibody (IgG1) agonist of human death receptor 5 (DR5…
Expand
2006
2006
Multi-parameter identification and control of turned surface textures
G. Petropoulos
,
C. Pandazaras
,
N. Vaxevanidis
,
A. Antoniadis
2006
Corpus ID: 55449788
A method for characterizing turned surface textures corresponding to varying cutting variables leading to differing profile shape…
Expand
2006
2006
Texture function application for wood ultrastructure description. Part 2: Application
W. Olek
,
J. Bonarski
Wood Science and Technology
2006
Corpus ID: 21013337
The practical application of the orientation distribution function (ODF), being the three-dimensional representation of the…
Expand
2006
2006
Salvage treatment with single-agent capecitabine in patients with heavily pretreated advanced colorectal cancer.
A. Ardavanis
,
G. Ioannidis
,
G. Orphanos
,
G. Rigatos
Anticancer Research
2006
Corpus ID: 38575010
BACKGROUND Refractory and/or relapsing advanced colorectal cancer (ACRC) requires frequent and prolonged hospitalisations, with a…
Expand
2005
2005
Multicenter, non-randomized phase II study with RPR109881 in taxane-exposed metastatic breast cancer (MBC) patients (pts): Final results
V. Diéras
,
V. Valero
,
+7 authors
M. Besenval
2005
Corpus ID: 74109266
565 Background: RPR109881 is a semisynthetic taxane with demonstrated broad spectrum of activity in in vivo tumor models…
Expand
Review
2005
Review
2005
Primary tumor of pancreatic cancer as a measurable target lesion in chemotherapy trials.
H. Ishii
,
J. Furuse
,
K. Nakachi
,
Eichiro Suzuki
,
M. Yoshino
Japanese Journal of Clinical Oncology
2005
Corpus ID: 7469942
BACKGROUND It is unclear whether primary pancreatic cancer (PC) tumors can be accepted as measurable target lesions in…
Expand
2003
2003
Nonlinear friction compensation in harmonic drives with hysteresis
R. Dhaouadi
IEEE International Conference on Advanced…
2003
Corpus ID: 61881313
In this paper, a new nonlinear observer-based controller is designed for the compensation of friction in harmonic drive systems…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE